Frazier, Vivo Add To Rempex's $67.5M In Fundraising
By Alex Ortolani · November 9, 2011, 6:13 PM EST
Rempex Pharmaceuticals Inc. raised $67.5 million in funding from investors including venture capital firms Frazier Healthcare Ventures and Vivo Ventures to continue developing treatments for bacteria resistant to antibiotics, the company...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login